Colchicine Neuropathy or Vitamin B12 Deficiency Neuropathy?

John J. Palopoli, Jack Waxman, Ralph W. Kuncl, Greg Duncan, Danny Watson, Kathy Alderson, Michael A Rogawski, Marilyn Peper

Research output: Contribution to journalLetter

10 Scopus citations


To the Editor: Kuncl et al. (June 18 issue)1 argued that colchicine myopathy may be a common disorder among patients who take customary doses of the drug (1.2 mg per day) for gout, and that the disorder is nearly always associated with a mild axonal polyneuropathy. They analyzed 12 cases to determine the primary risk factors but neglected to consider vitamin B12 deficiency as a possible cause of the associated neuropathies. Colchicine can induce the malabsorption of vitamin B12 by means of a dose-related, reversible reduction in the quantity of intrinsic-factor–vitamin B12 receptors in the intestinal mucosa….

Original languageEnglish (US)
Pages (from-to)1290-1291
Number of pages2
JournalNew England Journal of Medicine
Issue number20
StatePublished - Nov 12 1987
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Colchicine Neuropathy or Vitamin B<sub>12</sub> Deficiency Neuropathy?'. Together they form a unique fingerprint.

  • Cite this

    Palopoli, J. J., Waxman, J., Kuncl, R. W., Duncan, G., Watson, D., Alderson, K., Rogawski, M. A., & Peper, M. (1987). Colchicine Neuropathy or Vitamin B12 Deficiency Neuropathy? New England Journal of Medicine, 317(20), 1290-1291.